Clinical Trials
- Breast Cancer
I-SPY 2 Trial (Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2)
Birth Control and Genetics Study
- Ages18 years - 45 years
- GenderFemale only
- Breast Cancer
Use of DiviTum -TKa as a biomarker assay for CDK4/6 inhibitor medication compliance and drug-drug interactions assessment and intervention in HR-positive metastatic breast cancer patients
- Breast Cancer
Comparing Oral Drug Dosing Strategies in Older Patients With Metastatic Breast Cancer to Maximize Tolerance and Reduce Discontinuation: The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
- COVID-19 Inpatient, COVID-19 Outpatient
Biological, Behavioral, and Genetic Mechanisms in the Intergenerational Transmission of Toxic Stress
- Ages18 years and older
- GenderFemale only